Infant Mistakenly Given Insulin Dies Two Weeks Later
Infant Mistakenly Given Insulin Dies Two Weeks Later

It was revealed on Thursday by Saskatoon Health Region officials that four babies born prematurely at Royal University Hospital were given insulin by accident two weeks ago. The drug, which is used to regulate blood sugar, was mistaken for heparin, a drug used to control blood clots.

Officials did not disclose any of the infants’ health statuses at the time, but on Friday one mother reported that her six-week old son Andrew had died at the end of August. Bonnie Washam, Andrew’s mother, believes that there is a connection between the insulin error and her son’s death.

The Health Region has said that the child died from a lung infection that was unrelated to the error. One of the Region’s neonatalists, Dr. Laurentiu Givelichian, said that low sugar did not complicate the lung infection.

However, Calgary University’s Dr. David Lau, an expert on diabetes, warns against oversimplification. “I would be very cautious in categorically saying that the insulin dosage is not causative in the death of the infant.” Dr. Lau told CBC News that low blood sugar levels may have left the baby susceptible to infection.

Ms. Washam has announced her intentions to seek compensation for her loss, and is currently in the process of contacting a lawyer. Commenting on the whole situation, she said: “This isn’t a mistake that can be just swept under a run.”

Latest News

AMD announces ‘Seattle’ microprocessor for server systems
First baby born using 'safer' IVF method
GM recalling 193,652 SUVs from model years 2006 and 2007
Microsoft Office will take time to become available on tablets
Ofsted-style ratings for hospitals
Google to reveal some details about its high-flying balloons
Strong competition between Microsoft and Sony is good for industry: EA
Alcohol-related disease patients deserve better care
U.S. Navy ditches ALL CAPS message format
Nokia to unveil 41MP camera-equipped Lumia EOS smartphone next month
From 2016, Britain to regulate e-cigarettes as medicine
Sprint testing LTE cell sites in San Francisco